ALLERGAN INC·4

Jan 5, 2:42 PM ET

ROSSO LOUIS T 4

4 · ALLERGAN INC · Filed Jan 5, 2005

Insider Transaction Report

Form 4
Period: 2005-01-03
Transactions
  • Award

    Phantom Stock Units

    2004-12-09$77.98/sh+25.16$1,96221,823.15 total
    Common Stock (0 underlying)
  • Award

    Phantom Stock Units

    2005-01-03$80.31/sh+93.39$7,50021,916.54 total
    Common Stock (0 underlying)
Footnotes (4)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units accrued under the Allergan, Inc. Dividend Reinvestment Plan, exempt transaction under Rule 16a-11.
  • [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.
  • [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly portion of annual retainer.

Documents

1 file
  • 4
    ros330.xmlPrimary